A peptide triple agonist of GLP-1, neuropeptide Y1, and neuropeptide Y2 receptors promotes glycemic control and weight loss.
GLP-1、神經肽Y1和神經肽Y2受體的肽三重激動劑促進血糖控制和減重。
Sci Rep 2024-04-09
Effects of a long-acting secretin peptide analog alone and in combination with a GLP-1R agonist in a diet-induced obesity mouse model.
長效分泌素肽類似物單獨及與 GLP-1R 激動劑聯合在飲食誘導性肥胖小鼠模型中的影響。
Mol Metab 2023-07-19
GLP-1 receptor agonism and GIP receptor antagonism induce substantial alterations in enteroendocrine and islet cell populations in obese high fat fed mice.
GLP-1受體激動和GIP受體拮抗引起肥胖高脂飲食小鼠腸內分泌和胰島細胞族群的重大變化。
Peptides 2023-10-11
GLP-1 and PYY for the treatment of obesity: a pilot study on the use of agonists and antagonists in diet-induced rats.
GLP-1和PYY在肥胖治療中的應用:對飲食誘導大鼠使用激動劑和拮抗劑的初步研究。
Endocr Connect 2024-02-28
Loss of GIPR in LEPR cells impairs glucose control by GIP and GIP:GLP-1 co-agonism without affecting body weight and food intake in mice.
LEPR細胞中GIPR的喪失會影響小鼠的葡萄糖控制,而不影響體重和飲食攝入。
Mol Metab 2024-05-06
Neurocircuitry underlying the actions of glucagon-like peptide 1 and peptide YY<sub>3</sub><sub>-</sub><sub>36</sub> in the suppression of food, drug-seeking, and anxiogenesis.
葡萄糖樣肽1和多肽YY<sub>3</sub><sub>-</sub><sub>36</sub>在抑制食慾、尋求藥物和焦慮生成過程中的神經迴路。
Neuropeptides 2024-05-09
Systemic Co-Administration of Low-Dose Oxytocin and Glucagon-Like Peptide 1 Additively Decreases Food Intake and Body Weight.
低劑量催產素和類胰高血糖素1系統共同給藥可額外降低飲食攝取量和體重。
Neuroendocrinology 2024-05-22
The novel chimeric multi-agonist peptide (GEP44) reduces energy intake and body weight in male and female diet-induced obese mice in a glucagon-like peptide-1 receptor-dependent manner.
新型嵌合多激動肽 (GEP44) 以胰高血糖素樣肽-1 受體依賴的方式減少雄性和雌性飲食誘導肥胖小鼠的能量攝取和體重。
Front Endocrinol (Lausanne) 2024-08-06